Skip to content

EMDR & Primary dysmenorrhea

Investigating the effect of eye movement desensitization and reprocessing (EMDR) on pain intensity of primary dysmenorrhea

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180823040851N1
Enrollment
88
Registered
2018-10-06
Start date
2018-10-23
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: The intervention group will receive eye movement desensitization and reprocessing therapy for 6 therapeutic session, twice a week. The duration of the treatment sessions is 30 to 90 m

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Moderate to severe primary dysmenorrhea Single Reproductive age (18 to 45 years) Resident of dormitory of Qazvin University of Medical Sciences The desire to participate in the study

Exclusion criteria

Exclusion criteria: The presence of secondary dysmenorrhea and its underlying causes, such as the history of endometriosis, adenomyosis, sub acute endometriosis, pelvic inflammatory disease, copper intrauterine devices, ovarian cysts, congenital pelvic abnormality and cervical stenosis The history of known mental illnesses Drug Addiction History of seizure Strabismus and vision problems History of pelvic or abdominal surgery The probability of graduation during the follow-up period Cardiovascular and pulmonary respiratory disease

Design outcomes

Primary

MeasureTime frame
Pain intensity of primary dysmenorrhea. Timepoint: 1 and 2 months before intervention & 1 and 2 months after intervention. Method of measurement: Visual Analogue Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Valedi

Qazvin University of Medical Sciences

s.valedi@qums.ac.ir+98 28 3333 6003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 2, 2026